1 not yet recruiting, 1 terminated. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Not yet recruiting 1, Terminated 1 |
Follow Chronic Myeloid Leukemia (CML): new trials by email Literature Review of Chronic Myeloid Leukemia (CML) trials Research Report on Chronic Myeloid Leukemia (CML)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Randomized Study of ELVN-001 Versus Investigator-Selected TKI, in CP-CML Previously Treated With One or More TKIs ELVN-001, TKI - Chronic Myeloid Leukemia (CML), Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive | Phase 3 | Not yet recruiting | Enliven Therapeutics | 450 | 2026-12-31 | 2026-10-29 |
| Evaluation of a Cardiovascular Active Prevention in Chronic Myeloid Leukemia on the Cardiovascular Morbi-mortality Optimal medical treatment, usual clinical practice - Chronic Myeloid Leukemia (CML) | Phase 3 | Terminated | University Hospital, Angers | 80 | 2019-12-20 | 2025-03-17 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive (2) · Leukemia, Myeloid, Chronic-Phase (1) · Philadelphia Chromosome (1)
Bone Marrow Diseases (2) · Chronic Disease (2) · Disease Attributes (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Leukemia (2) · Leukemia, Myeloid (2) · Myeloproliferative Disorders (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Chromosome Aberrations (1) · Translocation, Genetic (1)
Dasatinib (1) · bosutinib (1) · nilotinib (1)
Enliven Therapeutics (1) · University Hospital, Angers (1)
France (1)